LOOKING FOR THERAPEUTIC ENTRY POINTS FOR ALZHEIMER’S DISEASE: LESSONS LEARNED FROM AGNOSTIC TRANS-CO-REGULATORY NETWORK ANALYSES OF APOE, TREM2, PLCG2 AND ABI3 LOCI